Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Given Consensus Rating of “Hold” by Analysts

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRXGet Rating) has been assigned an average recommendation of “Hold” from the nine ratings firms that are currently covering the firm, Marketbeat reports. Four research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $21.80.

Several research firms recently commented on MDRX. Piper Sandler lowered their target price on Allscripts Healthcare Solutions from $19.00 to $17.00 in a research note on Thursday, June 9th. KeyCorp started coverage on shares of Allscripts Healthcare Solutions in a research note on Thursday, September 15th. They set a “sector weight” rating on the stock. Finally, The Goldman Sachs Group assumed coverage on shares of Allscripts Healthcare Solutions in a research note on Tuesday, July 12th. They issued a “neutral” rating and a $21.00 price target for the company.

Insider Buying and Selling

In other Allscripts Healthcare Solutions news, CFO Leah Jones sold 7,000 shares of the stock in a transaction that occurred on Tuesday, September 13th. The shares were sold at an average price of $16.62, for a total value of $116,340.00. Following the transaction, the chief financial officer now directly owns 98,362 shares in the company, valued at $1,634,776.44. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, CEO Richard J. Poulton sold 10,000 shares of the business’s stock in a transaction dated Monday, August 15th. The stock was sold at an average price of $17.46, for a total value of $174,600.00. Following the completion of the sale, the chief executive officer now directly owns 742,517 shares of the company’s stock, valued at approximately $12,964,346.82. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Leah Jones sold 7,000 shares of the stock in a transaction on Tuesday, September 13th. The stock was sold at an average price of $16.62, for a total transaction of $116,340.00. Following the sale, the chief financial officer now owns 98,362 shares of the company’s stock, valued at approximately $1,634,776.44. The disclosure for this sale can be found here. Insiders sold a total of 20,945 shares of company stock worth $360,569 over the last 90 days. 2.29% of the stock is owned by insiders.

Institutional Trading of Allscripts Healthcare Solutions

A number of institutional investors have recently bought and sold shares of the company. C M Bidwell & Associates Ltd. purchased a new position in Allscripts Healthcare Solutions during the first quarter worth approximately $44,000. MQS Management LLC acquired a new stake in shares of Allscripts Healthcare Solutions in the second quarter valued at about $154,000. Prelude Capital Management LLC purchased a new stake in shares of Allscripts Healthcare Solutions during the 2nd quarter valued at about $156,000. AdvisorShares Investments LLC acquired a new position in Allscripts Healthcare Solutions during the 1st quarter worth approximately $186,000. Finally, Inspire Investing LLC lifted its position in Allscripts Healthcare Solutions by 37.9% during the 2nd quarter. Inspire Investing LLC now owns 14,360 shares of the software maker’s stock worth $213,000 after acquiring an additional 3,943 shares in the last quarter. 99.76% of the stock is currently owned by hedge funds and other institutional investors.

Allscripts Healthcare Solutions Trading Up 0.8 %

NASDAQ MDRX opened at $16.70 on Friday. The company has a debt-to-equity ratio of 0.17, a quick ratio of 3.23 and a current ratio of 3.23. The firm has a market cap of $1.85 billion, a price-to-earnings ratio of 38.84, a PEG ratio of 1.55 and a beta of 0.98. The firm has a 50 day simple moving average of $16.49 and a 200-day simple moving average of $18.06. Allscripts Healthcare Solutions has a one year low of $13.05 and a one year high of $23.25.

Allscripts Healthcare Solutions (NASDAQ:MDRXGet Rating) last released its earnings results on Thursday, August 4th. The software maker reported $0.18 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.15 by $0.03. The company had revenue of $150.90 million for the quarter, compared to analyst estimates of $148.58 million. Allscripts Healthcare Solutions had a net margin of 5.90% and a return on equity of 10.62%. The firm’s quarterly revenue was up 6.9% on a year-over-year basis. During the same period in the prior year, the business earned $0.17 EPS. Equities research analysts anticipate that Allscripts Healthcare Solutions will post 0.66 EPS for the current fiscal year.

About Allscripts Healthcare Solutions

(Get Rating)

Allscripts Healthcare Solutions, Inc, together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Featured Stories

Analyst Recommendations for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.